Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[To identify the promising alternative approach, we investigated the therapeutic potential of targeting the interleukin (IL)-8/CXCR2 pathway in colon cancer treatment using both loss-of-function (CXCR2 knockout) and gain-of-function (IL-8 overexpression) mouse models, as the IL-8/CXCR2 pathway has been shown to be activated in intestinal tumors of both human and experimental animals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP501123.RAfOoky7cfhkGLdupBPn0V3Jbno2ImganTFPrLIS1S2Xo130_assertion description "[To identify the promising alternative approach, we investigated the therapeutic potential of targeting the interleukin (IL)-8/CXCR2 pathway in colon cancer treatment using both loss-of-function (CXCR2 knockout) and gain-of-function (IL-8 overexpression) mouse models, as the IL-8/CXCR2 pathway has been shown to be activated in intestinal tumors of both human and experimental animals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501123.RAfOoky7cfhkGLdupBPn0V3Jbno2ImganTFPrLIS1S2Xo130_provenance.
• assertion description "[To identify the promising alternative approach, we investigated the therapeutic potential of targeting the interleukin (IL)-8/CXCR2 pathway in colon cancer treatment using both loss-of-function (CXCR2 knockout) and gain-of-function (IL-8 overexpression) mouse models, as the IL-8/CXCR2 pathway has been shown to be activated in intestinal tumors of both human and experimental animals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To identify the promising alternative approach, we investigated the therapeutic potential of targeting the interleukin (IL)-8/CXCR2 pathway in colon cancer treatment using both loss-of-function (CXCR2 knockout) and gain-of-function (IL-8 overexpression) mouse models, as the IL-8/CXCR2 pathway has been shown to be activated in intestinal tumors of both human and experimental animals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To identify the promising alternative approach, we investigated the therapeutic potential of targeting the interleukin (IL)-8/CXCR2 pathway in colon cancer treatment using both loss-of-function (CXCR2 knockout) and gain-of-function (IL-8 overexpression) mouse models, as the IL-8/CXCR2 pathway has been shown to be activated in intestinal tumors of both human and experimental animals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1137023.RAV3C18_Uj_925UpuqfaYTZkmBpV7LAYQ1Kvz4PlSoBMk130_assertion description "[To identify the promising alternative approach, we investigated the therapeutic potential of targeting the interleukin (IL)-8/CXCR2 pathway in colon cancer treatment using both loss-of-function (CXCR2 knockout) and gain-of-function (IL-8 overexpression) mouse models, as the IL-8/CXCR2 pathway has been shown to be activated in intestinal tumors of both human and experimental animals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1137023.RAV3C18_Uj_925UpuqfaYTZkmBpV7LAYQ1Kvz4PlSoBMk130_provenance.
• NP1137021.RADmeWY8NHea9eBgjUblKV9Lbz1F5duHxskx7OYDcwZF0130_assertion description "[To identify the promising alternative approach, we investigated the therapeutic potential of targeting the interleukin (IL)-8/CXCR2 pathway in colon cancer treatment using both loss-of-function (CXCR2 knockout) and gain-of-function (IL-8 overexpression) mouse models, as the IL-8/CXCR2 pathway has been shown to be activated in intestinal tumors of both human and experimental animals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1137021.RADmeWY8NHea9eBgjUblKV9Lbz1F5duHxskx7OYDcwZF0130_provenance.
• NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_assertion description "[To identify the promising alternative approach, we investigated the therapeutic potential of targeting the interleukin (IL)-8/CXCR2 pathway in colon cancer treatment using both loss-of-function (CXCR2 knockout) and gain-of-function (IL-8 overexpression) mouse models, as the IL-8/CXCR2 pathway has been shown to be activated in intestinal tumors of both human and experimental animals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_provenance.
• NP500800.RA9ZUM_n6h2vkGPDPhWQKs3soW_F7gE49JPtYobSLE4-I130_assertion description "[To identify the promising alternative approach, we investigated the therapeutic potential of targeting the interleukin (IL)-8/CXCR2 pathway in colon cancer treatment using both loss-of-function (CXCR2 knockout) and gain-of-function (IL-8 overexpression) mouse models, as the IL-8/CXCR2 pathway has been shown to be activated in intestinal tumors of both human and experimental animals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500800.RA9ZUM_n6h2vkGPDPhWQKs3soW_F7gE49JPtYobSLE4-I130_provenance.
• NP502005.RA1ZkPMyzbwCo3JvxEo6G0aEt44PQIQ6izx8Smqx6YVrY130_assertion description "[To identify the promising alternative approach, we investigated the therapeutic potential of targeting the interleukin (IL)-8/CXCR2 pathway in colon cancer treatment using both loss-of-function (CXCR2 knockout) and gain-of-function (IL-8 overexpression) mouse models, as the IL-8/CXCR2 pathway has been shown to be activated in intestinal tumors of both human and experimental animals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502005.RA1ZkPMyzbwCo3JvxEo6G0aEt44PQIQ6izx8Smqx6YVrY130_provenance.